Introducing Allday® 5000 Sensitive Toothpaste, the latest addition to Elevate Oral Care’s innovative line of prescription-strength toothpastes. Allday 5000 Sensitive does not contain SLS or CAPB. It uses the same next-generation glycolipid surfactant…
Read More...
Unlicensed Dental Providers Put Patients and the Profession at Risk
Reports of unlicensed individuals performing dental procedures are on the rise, leaving patients financially and physically harmed…
Precision Begins With Diagnosis
Accurate diagnosis is the cornerstone of predictable full-arch rehabilitation, especially in complex maxillary cases where anatomy,…
Real, Lasting Change Happens on the Patient’s Terms
True behavior change doesn’t happen because we tell patients what to do, but rather it happens when they discover their own reasons…
CMS Rule Cements the Importance of Oral and Systemic Health Integration
A new Centers for Medicare & Medicaid Services policy marks a major step toward integrating dentistry and medicine. By adding…
Weekly Popular
Personal Finance
More Top Stories
ADA Requests Oral Health Professionals Have First Crack at COVID-19 Vaccines
Kathleen T. O’Loughlin, DMD, MPH, executive director of the American Dental Association, asked members of a National Academies, Engineering, and Medicine panel—who are working on a plan for the equitable distribution of COVID-19 vaccines—to…
Practicing in the Land of the Midnight Sun
Katrina Virgin, RDH, MS, shares her insights on providing oral health care in the remote regions of Alaska during a global pandemic.
Study Calls for Reimagining of Dental Outreach Programs
While international travel may not be top-of-mind for most right now, many oral health professionals volunteer their time and expertise on dental mission trips. But how effective are these outreach programs?
Impact of COVID-19 on Dentistry Could Be Far-Reaching
The novel coronavirus pandemic has changed the landscape of our lives for the time being. But what is the overall impact of COVID-19 on 21st-century dentistry?
Public Health Departments Struggle to Prepare for Vaccine Rollout
While the United States has spent more than $10 billion on vaccine development, funds have not been allocated to support public health departments in rolling out two COVID-19 vaccines that may be ready as early as late October or the…
COVID-19 Cases Go Undiagnosed Among Frontline Healthcare Professionals
Approximately 69% of COVID-19 infections went undiagnosed among 3,000 frontline healthcare professionals between April and June in 12 states, according to new research published in the United States Morbidity and Mortality Weekly Report.…
Guardian Study: Eight in 10 Adults Say They Plan to Return to Dentist by Year-End 2020
Guardian's Workplace Benefits Study, "Dental Benefits 2020," reports nearly three in 10 patients say they are more anxious about visiting the dentist since the COVID-19 outbreak, however, 3 in 4 adults will be comfortable going to the…
Biopharmaceutical Industry Leaders Call for Principled Approach to COVID-19 Vaccines and Therapies
In a letter to the biopharmaceutical industry, CEOs from Ovid Therapeutics, Nkarta Therapeutics, Global Blood Therapeutics, Biotechnology Innovation Organization, Acorda Therapeutics, GlycoMimetics, Alnylam Pharmaceuticals, and Alkermes…
Supporting Enamel in Soft Drink Consumers
This information is from the article What Advice Can Be Offered to Patients with Soft Tooth Enamel? By Martha McComas, RDH, MS. To read the article, click here.
CDC Says Two Vaccines Will Be Ready by October or November
As yet unidentified, Vaccine A and Vaccine B should be ready for national distribution by late October or early November, according to the United States Centers for Disease Control and Prevention (CDC). The vaccines will initially be used…
Market Media
- Advertisement -
